查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087896

植入市場：按產品類型、材料、最終用戶和分銷管道分類的全球市場預測，2026-2032年

Bio-implant Market by Product Type, Material, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，植入市場將成長至 2,453.2 億美元，複合年成長率為 7.99%。

主要市場統計數據
基準年 2025 1432.1億美元
預計年份：2026年 1527.9億美元
預測年份：2032年 2453.2億美元
複合年成長率 (%) 7.99%

植入市場概覽

植入正從醫療設備為中心的產品轉向以數據驅動的治療平台，其應用領域涵蓋整形外科、循環系統醫學、牙科重組、眼科、神經調控和組織修復等眾多領域。人口老化、慢性病盛行率上升以及外科手術可及性的提高是推動生物植入物需求成長的主要因素。心血管疾病仍是全球首要死因，口腔疾病影響全球約35億人，因此，心血管、牙科和重組領域對植入解決方案的長期需求日益成長。

植入領域的變革性變化

競爭格局正朝著個人化、生物相容性和數位化驅動的植入方向發展。積層製造技術能夠實現針對患者最佳化的整形外科和顱顎顏面植入，而表面工程、抗菌塗層和生物可吸收材料則可改善骨整合並降低併發症風險。美國FDA和歐洲監管機構等組織持續強調臨床證據、上市後監測和醫療設備可追溯性，提升了品管系統和生命週期資料的重要性。

人工智慧（AI）對植入的累積影響

人工智慧 (AI) 正成為整個植入價值鏈中一股實質的驅動力。在研發領域，AI 模型可輔助材料選擇、有限元素分析、植入設計最佳化以及生物相容性風險的快速篩檢。在臨床規劃領域，AI 驅動的影像技術可幫助外科醫生評估骨骼品質、解剖結構對位以及植入尺寸，尤其是在整形外科、牙科和脊椎外科手術中。

植入的關鍵區域見解

北美憑藉其先進的醫院基礎設施、龐大的手術量、完善的保險報銷體係以及美國和加拿大強大的醫療技術創新能力，繼續保持著植入市場的主導地位。慢性疾病、運動傷害、牙齒修復需求以及人口老化帶來的整形外科、循環系統和神經調節植入需求，進一步推動了市場需求。公共衛生數據顯示，心血管疾病負擔持續加重，且對肌肉骨骼手術的需求不斷成長，這些因素持續推動著經臨床驗證的植入式解決方案的普及應用。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

在新加坡、泰國、馬來西亞、印尼、越南和菲律賓等市場，東協作為植入成長中心的重要性日益凸顯，這主要得益於私立醫院的擴張、牙科旅遊的興起以及整形外科和心血管手術服務可及性的提高。海灣合作理事會（GCC）正透過國家醫療改革計畫建造先進的醫療中心，以滿足對高階植入、機器人手術、國際認證的專科醫療服務以及進口和本地支援的醫療技術的需求。

植入市場成長的關鍵國家洞察

美國是最具影響力的市場，這得益於FDA監管下的強勁創新、先進外科技術的廣泛應用以及對整形外科、循環系統、牙科、眼科和神經刺激植入的巨大需求。加拿大受惠於其全民健保體系和成熟的專科醫生網路，而墨西哥則兼具國內需求以及醫療旅遊和近岸外包的潛力。巴西是拉丁美洲最大的醫療市場，也是牙科、整形外科、循環系統和重組植入的重要市場。

植入產業領導者使用的實用建議

產業領導企業應優先發展具有臨床差異化優勢的產品，這些產品能夠降低再次手術的風險，促進患者更快康復，並展現出可衡量的健康經濟價值。投資於生物相容性材料、抗菌表面、個人化植入、微創輸送系統、互聯監測以及人工智慧驅動的手術規劃，可以加劇高階市場和成本敏感型市場的競爭。

調查方法

本執行摘要採用系統的二手資料研究方法編寫，重點關注檢驗的公共資訊來源，例如衛生組織、監管機構、醫療政策出版刊物、同行評審文獻、臨床指南、公共研究途徑資訊以及全球認可的行業資料庫。關鍵指標包括疾病負擔、人口老化、手術普及率、監管變化、報銷趨勢、醫療基礎設施以及醫療技術創新。

結論

植入產業正步入一個臨床、監管和技術方面都面臨更高期望的時期。推動產業成長的因素包括人口老化、慢性病盛行率上升、外科手術覆蓋範圍擴大、創傷和牙科治療需求增加，以及對耐用且以患者為中心的解決方案的需求。同時，成功越來越依賴證據品質、價格可負擔性、供應鏈韌性、監管準備和數位整合。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：植入市場：依產品類型分類

  • 心血管植入
    • 人工心臟瓣膜
    • 心律調節器
    • 支架
    • 血管移植
  • 牙科植體
    • 骨內植入
    • 骨膜下植入
    • 骨內植入
  • 神經系統植入
    • 深部腦部刺激器
    • 神經義肢
    • 脊髓刺激設備
  • 眼科植入
    • 角膜植入
    • 人工水晶體
    • 視網膜植入
  • 整形外科植入
    • 髖關節植入
      • 髖關節表面置換術
      • 全髖關節置換術
    • 膝關節植入
      • 部分膝關節關節重建手術
      • 全膝關節置換術
    • 肩關節植入
    • 脊椎移植

第8章：植入市場：依材料分類

  • 陶瓷製品
  • 複合材料
  • 聚合物
    • 可生物分解聚合物
    • UHMWPE
  • 鈦

第9章：植入市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院
  • 研究機構

第10章：植入市場：依通路分類

  • 離線
  • 線上

第11章：植入市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：植入市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：植入市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • AAP Implantate AG
  • Abbott Laboratories
  • Align Technology Inc
  • Alphatec Holdings Inc
  • Alphatec Spine Inc
  • Arthrex Inc
  • BioHorizons Inc
  • BIoTronik SE & Co KG
  • Boston Scientific Corporation
  • Cochlear Limited
  • CONMED Corporation
  • Dentium Co Ltd
  • Dentsply Sirona Inc
  • Envista Holdings Corporation
  • Exactech Inc
  • Globus Medical Inc
  • Heraeus Medical GmbH
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • MegaGen Implant Co Ltd
  • MiMedx Group Inc
  • Organogenesis Holdings Inc
  • Osstem Implant Co Ltd
  • SINTX Technologies Inc
  • Smith & Nephew PLC
  • Straumann Holding AG
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc
Product Code: MRR-0355054AC501

The Bio-implant Market is projected to grow by USD 245.32 billion at a CAGR of 7.99% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 143.21 billion
Estimated Year [2026] USD 152.79 billion
Forecast Year [2032] USD 245.32 billion
CAGR (%) 7.99%

Bio-Implant Market Introduction

Bio-implants are moving from device-centric products to data-informed therapeutic platforms used across orthopedics, cardiovascular care, dental reconstruction, ophthalmology, neuromodulation, and tissue repair. Demand is structurally supported by aging populations, chronic disease prevalence, and improved surgical access. The World Health Organization reports that cardiovascular diseases remain the world's leading cause of death, while oral diseases affect an estimated 3.5 billion people globally, reinforcing long-term need for cardiovascular, dental, and reconstructive bio-implant solutions.

The bio-implant market is also being shaped by advances in biocompatible materials, 3D printing, regenerative medicine, minimally invasive surgery, and connected post-operative monitoring. Hospitals, ambulatory surgical centers, and specialty clinics increasingly evaluate implants not only by clinical performance but also by durability, infection risk, reimbursement fit, supply reliability, and evidence generated through real-world data.

Transformative Shifts in the Bio-Implant Landscape

The competitive landscape is shifting toward personalized, biologically integrated, and digitally enabled implants. Additive manufacturing enables patient-specific orthopedic and cranio-maxillofacial implants, while surface engineering, antimicrobial coatings, and bioresorbable materials are improving osseointegration and reducing complication risk. Regulatory bodies such as the U.S. FDA and European authorities continue to emphasize clinical evidence, post-market surveillance, and device traceability, increasing the importance of quality systems and lifecycle data.

Healthcare systems are also prioritizing value-based purchasing. Implant manufacturers must demonstrate measurable improvements in patient outcomes, revision rates, operating-room efficiency, and total cost of care. This is encouraging partnerships among medtech companies, material science firms, AI developers, contract manufacturers, and healthcare providers to accelerate innovation while strengthening supply chain resilience.

Cumulative Impact of Artificial Intelligence on Bio-Implants

Artificial intelligence is becoming a practical accelerator across the bio-implant value chain. In research and development, AI models support material selection, finite element analysis, implant design optimization, and faster screening of biocompatibility risks. In clinical planning, AI-assisted imaging can help surgeons evaluate bone quality, anatomical alignment, and implant sizing, especially in orthopedic, dental, and spinal procedures.

The cumulative impact of AI is strongest when combined with real-world evidence and connected care. Predictive analytics can identify patients at higher risk of implant failure, infection, or readmission, enabling earlier intervention. For manufacturers, AI improves demand planning, quality inspection, adverse event signal detection, and regulatory documentation workflows. However, AI adoption must remain aligned with clinical validation, cybersecurity, patient privacy, and transparent model governance.

Key Regional Insights for Bio-Implants

North America remains a leading bio-implant market due to advanced hospital infrastructure, high procedure volumes, established reimbursement pathways, and strong medtech innovation in the United States and Canada. Demand is reinforced by chronic disease burden, sports injuries, dental restoration needs, and an aging population requiring orthopedic, cardiovascular, ophthalmic, and neuromodulation implants. Public health data showing sustained cardiovascular disease burden and musculoskeletal procedure demand continue to support adoption of clinically proven implantable solutions.

Europe benefits from mature healthcare systems, strong regulatory oversight, and a large base of orthopedic, dental, and cardiovascular device capabilities. The European Union's Medical Device Regulation has increased evidence requirements, which favors organizations with robust clinical data, quality management systems, traceability, and post-market surveillance capabilities. Asia-Pacific is a fast-developing opportunity area, supported by expanding healthcare access, medical tourism, rising middle-class spending, and large patient populations in China, India, Japan, South Korea, ASEAN economies, and Australia.

Latin America shows steady demand led by Brazil and Mexico, where private healthcare investment, dental implant adoption, and access to specialist surgery are improving. The Middle East is investing in specialty hospitals, medical tourism, and advanced surgical capabilities, particularly across GCC economies where healthcare modernization programs emphasize high-acuity care. Africa remains comparatively underpenetrated, but long-term prospects are supported by urbanization, gradual healthcare infrastructure investment, and rising demand for trauma, dental, orthopedic, and reconstructive care.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is gaining relevance as a bio-implant growth corridor due to expanding private hospitals, rising dental tourism, and improving access to orthopedic and cardiovascular procedures in markets such as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is building advanced medical hubs through national healthcare transformation programs, supporting demand for premium implants, robotic surgery, internationally accredited specialty care, and imported as well as locally supported medical technologies.

The European Union remains a critical regulatory and commercial bloc where compliance with MDR, clinical evidence generation, medical device traceability, and sustainability expectations influence market entry and portfolio strategy. BRICS economies are important for volume expansion because Brazil, Russia, India, China, and South Africa combine large patient populations with increasing domestic manufacturing capabilities, public procurement reforms, and cost-sensitive healthcare environments.

G7 countries represent high-value demand for advanced bio-implants, including smart orthopedic systems, dental implants, neurostimulation devices, ophthalmic implants, and next-generation cardiovascular implants. NATO members overlap significantly with major regulated healthcare markets, where supply security, medical technology resilience, cybersecurity, and trusted manufacturing networks are becoming more strategically important for implantable medical devices.

Key Country Insights for Bio-Implant Growth

The United States is the most influential country market, driven by strong FDA-regulated innovation, high adoption of advanced surgical technologies, and significant demand for orthopedic, cardiovascular, dental, ophthalmic, and neurostimulation implants. Canada benefits from universal healthcare coverage and a mature specialist network, while Mexico combines domestic demand with medical tourism and nearshoring potential. Brazil is Latin America's largest healthcare market and is important for dental, orthopedic, cardiovascular, and reconstructive implants.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show sustained demand due to aging populations, established surgical capacity, and strong clinical standards. Germany is particularly important for engineering, precision manufacturing, and orthopedic innovation, while France, Italy, and Spain support broad uptake across public and private healthcare channels. Russia remains a complex market due to procurement localization, import substitution policies, regulatory requirements, and geopolitical constraints affecting medical technology access.

China and India offer substantial long-term expansion due to large patient populations, rising procedure volumes, broader insurance coverage, and increasing domestic production of implantable medical devices. Japan and South Korea are advanced markets with strong adoption of precision medical technologies, aging-related orthopedic and dental needs, and high-quality hospital systems. Australia maintains stable demand supported by an aging population, strong regulatory standards, trauma care capacity, and advanced orthopedic and dental care access.

Actionable Recommendations for Bio-Implant Industry Leaders

Industry leaders should prioritize clinically differentiated products that reduce revision risk, support faster recovery, and demonstrate measurable health-economic value. Investment in biocompatible materials, antimicrobial surfaces, patient-specific implants, minimally invasive delivery systems, connected monitoring, and AI-supported surgical planning can improve competitiveness in both premium and cost-sensitive markets.

Organizations should also strengthen regulatory intelligence, post-market surveillance, adverse event monitoring, and real-world evidence programs to meet rising expectations from regulators, payers, surgeons, and hospital procurement teams. Strategic localization in Asia-Pacific, Latin America, and the Middle East can improve affordability and market access, while resilient supplier networks, qualified alternate materials, and dual-source manufacturing can reduce disruption risk.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified public sources, including global health agencies, regulatory authorities, healthcare policy publications, peer-reviewed literature, clinical guidance, public procurement information, and recognized industry databases. Core indicators include disease burden, population aging, surgical adoption, regulatory change, reimbursement dynamics, healthcare infrastructure, and medical technology innovation.

Insights are triangulated across regional healthcare infrastructure, implant category adoption, regulatory frameworks, competitive activity, and macroeconomic indicators. Qualitative interpretation emphasizes data-backed trends rather than unsupported projections, ensuring the analysis remains suitable for executive decision-making.

Conclusion

The bio-implant industry is entering a period of higher clinical, regulatory, and technological expectations. Growth drivers include aging demographics, chronic disease prevalence, rising surgical access, trauma and dental care needs, and demand for durable, patient-specific solutions. At the same time, success increasingly depends on evidence quality, affordability, supply chain resilience, regulatory readiness, and digital integration.

Manufacturers that combine biomaterials expertise, AI-enabled design, real-world evidence, and regional market adaptation will be best positioned to address opportunities across established and emerging markets. The next phase of bio-implant competition will reward organizations that deliver safer implants, better outcomes, lower complication risk, and stronger value across the full patient care pathway.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Bio-implant Market, by Product Type

  • 7.1. Cardiovascular Implants
    • 7.1.1. Artificial Heart Valves
    • 7.1.2. Pacemakers
    • 7.1.3. Stents
    • 7.1.4. Vascular Grafts
  • 7.2. Dental Implants
    • 7.2.1. Endosseous Implants
    • 7.2.2. Subperiosteal Implants
    • 7.2.3. Transosteal Implants
  • 7.3. Neurological Implants
    • 7.3.1. Deep Brain Stimulators
    • 7.3.2. Neuroprosthetics
    • 7.3.3. Spinal Cord Stimulators
  • 7.4. Ophthalmic Implants
    • 7.4.1. Corneal Implants
    • 7.4.2. Intraocular Lenses
    • 7.4.3. Retinal Implants
  • 7.5. Orthopedic Implants
    • 7.5.1. Hip Implants
      • 7.5.1.1. Hip Resurfacing
      • 7.5.1.2. Total Hip Replacement
    • 7.5.2. Knee Implants
      • 7.5.2.1. Partial Knee Replacement
      • 7.5.2.2. Total Knee Replacement
    • 7.5.3. Shoulder Implants
    • 7.5.4. Spinal Implants

8. Bio-implant Market, by Material

  • 8.1. Ceramic
  • 8.2. Composite
  • 8.3. Polymer
    • 8.3.1. Biodegradable Polymers
    • 8.3.2. Uhmwpe
  • 8.4. Titanium

9. Bio-implant Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Clinics
  • 9.3. Hospitals
  • 9.4. Research Institutes

10. Bio-implant Market, by Distribution Channel

  • 10.1. Offline
  • 10.2. Online

11. Bio-implant Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Bio-implant Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Bio-implant Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. AAP Implantate AG
  • 15.2. Abbott Laboratories
  • 15.3. Align Technology Inc
  • 15.4. Alphatec Holdings Inc
  • 15.5. Alphatec Spine Inc
  • 15.6. Arthrex Inc
  • 15.7. BioHorizons Inc
  • 15.8. Biotronik SE & Co KG
  • 15.9. Boston Scientific Corporation
  • 15.10. Cochlear Limited
  • 15.11. CONMED Corporation
  • 15.12. Dentium Co Ltd
  • 15.13. Dentsply Sirona Inc
  • 15.14. Envista Holdings Corporation
  • 15.15. Exactech Inc
  • 15.16. Globus Medical Inc
  • 15.17. Heraeus Medical GmbH
  • 15.18. Integra LifeSciences Holdings Corporation
  • 15.19. Johnson & Johnson
  • 15.20. Medtronic plc
  • 15.21. MegaGen Implant Co Ltd
  • 15.22. MiMedx Group Inc
  • 15.23. Organogenesis Holdings Inc
  • 15.24. Osstem Implant Co Ltd
  • 15.25. SINTX Technologies Inc
  • 15.26. Smith & Nephew PLC
  • 15.27. Straumann Holding AG
  • 15.28. Stryker Corporation
  • 15.29. Zimmer Biomet Holdings Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIO-IMPLANT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BIO-IMPLANT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BIO-IMPLANT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BIO-IMPLANT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-IMPLANT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL BIO-IMPLANT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BIO-IMPLANT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BIO-IMPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL HEART VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL HEART VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PACEMAKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PACEMAKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PACEMAKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSSEOUS IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSSEOUS IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSSEOUS IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SUBPERIOSTEAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SUBPERIOSTEAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SUBPERIOSTEAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL TRANSOSTEAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TRANSOSTEAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TRANSOSTEAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROLOGICAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DEEP BRAIN STIMULATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DEEP BRAIN STIMULATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DEEP BRAIN STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROPROSTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROPROSTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SPINAL CORD STIMULATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SPINAL CORD STIMULATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SPINAL CORD STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL OPHTHALMIC IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OPHTHALMIC IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OPHTHALMIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORNEAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CORNEAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORNEAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAOCULAR LENSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAOCULAR LENSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAOCULAR LENSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RETINAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RETINAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RETINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIP IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HIP IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HIP RESURFACING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIP RESURFACING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HIP RESURFACING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TOTAL HIP REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TOTAL HIP REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TOTAL HIP REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL KNEE IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL KNEE IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL KNEE IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PARTIAL KNEE REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PARTIAL KNEE REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PARTIAL KNEE REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TOTAL KNEE REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TOTAL KNEE REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TOTAL KNEE REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SHOULDER IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SHOULDER IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SHOULDER IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SPINAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SPINAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CERAMIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CERAMIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CERAMIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL COMPOSITE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL COMPOSITE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL COMPOSITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL POLYMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL POLYMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL POLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL UHMWPE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL UHMWPE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL UHMWPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL TITANIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL TITANIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL TITANIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIO-IMPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. GCC BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. GCC BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 216. GCC BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 218. GCC BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 221. GCC BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 223. GCC BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 224. GCC BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. GCC BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. G7 BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. G7 BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. G7 BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 256. G7 BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 257. G7 BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 258. G7 BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 259. G7 BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 260. G7 BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 261. G7 BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 262. G7 BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 263. G7 BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. G7 BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. NATO BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. NATO BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. NATO BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 268. NATO BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 269. NATO BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 270. NATO BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 271. NATO BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 272. NATO BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 273. NATO BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 274. NATO BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 275. NATO BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 276. NATO BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. NATO BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 278. GLOBAL BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 292. CANADA BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. CANADA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. CANADA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 295. CANADA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 296. CANADA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 297. CANADA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 298. CANADA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 299. CANADA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 300. CANADA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 301. CANADA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 302. CANADA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 303. CANADA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. CANADA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 305. MEXICO BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 306. MEXICO BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. MEXICO BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 308. MEXICO BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 309. MEXICO BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 310. MEXICO BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 311. MEXICO BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 312. MEXICO BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 313. MEXICO BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 314. MEXICO BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 315. MEXICO BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 316. MEXICO BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. MEXICO BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 318. BRAZIL BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 319. BRAZIL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. BRAZIL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 321. BRAZIL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 322. BRAZIL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 323. BRAZIL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 324. BRAZIL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 325. BRAZIL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 326. BRAZIL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 327. BRAZIL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 328. BRAZIL BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 329. BRAZIL BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 330. BRAZIL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 343. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 344. GERMANY BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 345. GERMANY BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 346. GERMANY BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 347. GERMANY BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 348. GERMANY BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 349. GERMANY BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 350. GERMANY BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 351. GERMANY BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 352. GERMANY BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 353. GERMANY BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 354. GERMANY BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 355. GERMANY BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 356. GERMANY BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 357. FRANCE BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 358. FRANCE BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 359. FRANCE BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 360. FRANCE BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 361. FRANCE BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 362. FRANCE BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 363. FRANCE BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 364. FRANCE BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 365. FRANCE BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 366. FRANCE BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 367. FRANCE BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 368. FRANCE BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 369. FRANCE BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 370. RUSSIA BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 371. RUSSIA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 372. RUSSIA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 373. RUSSIA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 374. RUSSIA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 375. RUSSIA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 376. RUSSIA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 377. RUSSIA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 378. RUSSIA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 379. RUSSIA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 380. RUSSIA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 381. RUSSIA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 382. RUSSIA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 383. ITALY BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 384. ITALY BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)

TABLE 3